Narrow your search

Library

KU Leuven (7)

ULiège (7)

VDIC (7)

UGent (1)


Resource type

book (15)


Language

English (15)


Year
From To Submit

2004 (15)

Listing 1 - 10 of 15 << page
of 2
>>
Sort by

Book
Guidance for industry : changes to an approved NDA or ANDA.
Author:
Year: 2004 Publisher: Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Keywords

Drug approval


Book
Guidance for industry : changes to an approved NDA or ANDA, specifications, use of enforcement discretion for compendial changes.
Author:
Year: 2004 Publisher: Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Keywords

Drug approval


Book
Guidance for industry : changes to an approved NDA or ANDA, specifications, use of enforcement discretion for compendial changes.
Author:
Year: 2004 Publisher: Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Keywords

Drug approval


Book
Guidance for industry : changes to an approved NDA or ANDA.
Author:
Year: 2004 Publisher: Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Keywords

Drug approval


Book
Guidance for industry : listed drugs, 30 month stays, and approval of ANDAs and 505(b)(2) applications under Hatch-Waxman, as amended by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, questions and answers.
Author:
Year: 2004 Publisher: Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Guidance for industry : listed drugs, 30 month stays, and approval of ANDAs and 505(b)(2) applications under Hatch-Waxman, as amended by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, questions and answers.
Author:
Year: 2004 Publisher: Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Guidance for industry : botanical drug products.
Author:
Year: 2004 Publisher: Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Guidance for industry : botanical drug products.
Author:
Year: 2004 Publisher: Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Drugs@FDA
Author:
Year: 2004 Publisher: Washington D.C. : U.S. Food and Drug Administration, Center for Drug and Evaluation Research.

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Drugs@FDA
Author:
Year: 2004 Publisher: Washington D.C. : U.S. Food and Drug Administration, Center for Drug and Evaluation Research.

Loading...
Export citation

Choose an application

Bookmark

Abstract

Listing 1 - 10 of 15 << page
of 2
>>
Sort by